SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-21-000086
Filing Date
2021-02-08
Accepted
2021-02-08 10:51:02
Documents
13
Period of Report
2021-01-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 01-01-2021 form_8-k.htm   iXBRL 8-K 23110
2 PRESS RELEASE DATED FEBRUARY 4, 2021 ex_99-1.htm EX-99 8113
  Complete submission text file 0001161697-21-000086.txt   204470

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE sgni-20210101.xsd EX-101.SCH 3184
4 XBRL PRESENTATION FILE sgni-20210101_pre.xml EX-101.PRE 22709
5 XBRL LABEL FILE sgni-20210101_lab.xml EX-101.LAB 34592
6 EXTRACTED XBRL INSTANCE DOCUMENT form_8-k_htm.xml XML 3276
Mailing Address 1 PERFORMANCE DRIVE, SUITE F ANGLETON TX 77515
Business Address 1 PERFORMANCE DRIVE, SUITE F ANGLETON TX 77515 832-954-7569
StemGen, Inc. (Filer) CIK: 0001023198 (see all company filings)

IRS No.: 541812385 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-21555 | Film No.: 21599969
SIC: 7372 Services-Prepackaged Software